CervoMed (CRVO)
NASDAQ:CRVO
Total Valuation
CervoMed has a market cap or net worth of $35.55M. The enterprise value is $27.32M.
Market Cap$35.55M
Enterprise Value$27.32M
Share Statistics
CervoMed has 9,258,719 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,258,719
Owned by Insiders44.08%
Owned by Institutions10.03%
Financial Efficiency
CervoMed’s return on equity (ROE) is -1.48 and return on invested capital (ROIC) is -150.96%.
Return on Equity (ROE)-1.48
Return on Assets (ROA)-1.15
Return on Invested Capital (ROIC)-150.96%
Return on Capital Employed (ROCE)-1.51
Revenue Per Employee267.10K
Profits Per Employee-1.80M
Employee Count15
Asset Turnover0.17
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of CervoMed is ―. CervoMed’s PEG ratio is -0.06.
PE Ratio―
PS Ratio17.83
PB Ratio3.92
Price to Fair Value3.92
Price to FCF-3.05
Price to Operating Cash Flow-1.52
PEG Ratio-0.06
Income Statement
In the last 12 months, CervoMed had revenue of 4.01M and earned -26.97M in profits. Earnings per share was -2.98.
Revenue4.01M
Gross Profit0.00
Operating Income-28.29M
Pretax Income-26.97M
Net Income-26.97M
EBITDA-28.29M
Earnings Per Share (EPS)-2.98
Cash Flow
In the last 12 months, operating cash flow was -23.45M and capital expenditures -5.00, giving a free cash flow of -23.45M billion.
Operating Cash Flow-23.45M
Free Cash Flow-23.45M
Free Cash Flow per Share-2.53
Dividends & Yields
CervoMed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.05
52-Week Price Change-53.85%
50-Day Moving Average4.50
200-Day Moving Average7.22
Relative Strength Index (RSI)41.35
Average Volume (3m)112.80K
Important Dates
CervoMed upcoming earnings date is May 19, 2026, Before Open (Confirmed).
Last Earnings DateMar 17, 2026
Next Earnings DateMay 19, 2026
Ex-Dividend Date―
Financial Position
CervoMed as a current ratio of 4.84, with Debt / Equity ratio of 0.00%
Current Ratio4.84
Quick Ratio4.84
Debt to Market Cap0.00
Net Debt to EBITDA0.29
Interest Coverage Ratio0.00
Taxes
In the past 12 months, CervoMed has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CervoMed EV to EBITDA ratio is -2.23, with an EV/FCF ratio of -2.69.
EV to Sales15.77
EV to EBITDA-2.23
EV to Free Cash Flow-2.69
EV to Operating Cash Flow-2.69
Balance Sheet
CervoMed has $20.86M in cash and marketable securities with $0.00 in debt, giving a net cash position of $20.86M billion.
Cash & Marketable Securities$20.86M
Total Debt$0.00
Net Cash$20.86M
Net Cash Per Share$2.25
Tangible Book Value Per Share$2.02
Margins
Gross margin is 100.00%, with operating margin of -706.22%, and net profit margin of -673.06%.
Gross Margin100.00%
Operating Margin-706.22%
Pretax Margin-673.06%
Net Profit Margin-673.06%
EBITDA Margin-706.22%
EBIT Margin-706.22%
Analyst Forecast
The average price target for CervoMed is $20.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$20.80
Price Target Upside441.67% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast-38.81%
EPS Growth Forecast-76.96%